1. Most Discussed
  2. Gainers & Losers
NRT 4.2¢

joint ventures

  1. munch

    3,567 posts.
    This suggests we should be on the verge of seeing more "joint ventures" such as the Yale or NIH relationships eventuate for NV-04 and NV-07. I guess all these institutions can't be wrong in their enthusiasm... all NV-04 needs is some research to produce results like the Yale research did on Phenoxodiol.

    "With Novogen’s lead anti-cancer compound, phenoxodiol, now being developed by our subsidiary Marshall Edwards, Inc. an extraordinary situation exists. Not one line of investigation that has been performed todate has lead to a dead end. Every single study has demonstrated some potential for therapeutic efficacy and provided more knowledge on how the cancer disease process works and the role that phenoxodiol might play in controlling that disease.

    We have now reached a stage where major research groups working in the cancer field such as the National Institutes of Health and Yale University Medical School want to work with phenoxodiol because, of all the compounds available to them, phenoxodiol is one of the most exciting.

    The Board is confident that not only will this work lead to ultimate commercial success but that other Novogen programs such as NV-04 and NV-07 are at the threshold of escalating understanding and interest in the cardiovascular and dermatological areas.

DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.

Top